A carregar...
Chronic carbamazepine administration reduces NMDA receptor-initiated signaling via arachidonic acid in rat brain
BACKGROUND: Lithium and carbamazepine (CBZ) are used to treat mania in bipolar disorder. When given chronically to rats, both agents reduce brain arachidonic acid (AA) turnover in brain phospholipids and downstream AA metabolism. Lithium administration to rats also attenuates N-methyl-D-aspartic aci...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2007
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2131715/ https://ncbi.nlm.nih.gov/pubmed/17628508 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biopsych.2007.04.021 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|